Cargando…
Impact of Fc N-linked glycans on in vivo clearance of an immunoglobulin G1 antibody produced by NS0 cell line
The heterogeneity of glycosylation on therapeutic monoclonal antibodies (mAbs) may affect the safety and efficacy of these agents. In particular, glycans of nonhuman origin, such as galactose-alpha-1,3-galactose (gal-α-gal) and N-glycolylneuraminic acid (NGNA), in the Fc region of therapeutic mAbs p...
Autores principales: | Kim, Jun, Luo, Haibin, White, Wendy, Rees, William, Venkat, Raghavan, Albarghouthi, Methal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671047/ https://www.ncbi.nlm.nih.gov/pubmed/33171078 http://dx.doi.org/10.1080/19420862.2020.1844928 |
Ejemplares similares
-
Rapid monitoring of high‐mannose glycans during cell culture process of therapeutic monoclonal antibodies using lectin affinity chromatography
por: Kim, Jun, et al.
Publicado: (2022) -
Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa
por: Sakae, Yoshitake, et al.
Publicado: (2017) -
Distinct Fcα receptor N-glycans modulate the binding affinity to immunoglobulin A (IgA) antibodies
por: Göritzer, Kathrin, et al.
Publicado: (2019) -
Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities
por: Dekkers, Gillian, et al.
Publicado: (2017) -
Fc glycans of therapeutic antibodies as critical quality attributes
por: Reusch, Dietmar, et al.
Publicado: (2015)